Video
Mesenchymal Stromal Cells (MSCs) for Biologic-Refractory Psoriasis.
In this Take Ten with IPC video, Professor Christopher Griffiths and Dr. Su Lwin discuss their recent publication on…
In this Take Ten with IPC video, Professor Christopher Griffiths and Dr. Su Lwin discuss their recent publication on…
Watch VideoIPC Honorary Founder Christopher Griffiths discusses the history and development of the Global Psoriasis Atlas, a…
Watch VideoThis article provides an evidence-based update on psoriasis in individuals with skin of color (SOC), highlighting…
View ReportDr. Tiago Torres examines palmoplantar and nail psoriasis and further investigates the treatment options and therapies…
Watch VideoIPC GLOBAL WEBINAR SERIES Program chairs: Elfie Deprez, Belgium and Chris Griffiths, United Kingdom Program faculty:…
10TH INTERNATIONAL CONGRESS | LONDON, UNITED KINGDOM.
Discover the latest updates on psoriasis from the World Congress of Dermatology (WCD) 2023, hosted in Singapore from…
Read MoreProfessor Griffiths discusses taking the trial and error out of treatments plans and moving to target to treat.
Watch VideoThe 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023,…
Read MoreThe 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023,…
View ReportAMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING (AAD) | NEW ORLEANS, LA Thursday, March 16 14:00 - 17:00…
Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank…
Read MoreThe European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…
Read MoreThe Global Psoriasis Atlas (GPA) is a joint project of the ILDS (International League of Dermatological Societies),…
Read MoreWORLD CONGRESS OF DERMATOLOGY (WCD) | SINGAPORE Monday, July 3 14:30 - 17:30 SGT Program chairs: Claudia de la…
Held virtually on December 11 due to the Coronavirus Pandemic, the 2020 IPC Think Tank convened more than 100…
Read MoreView Report
View Report
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.